UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Gilead launches new, improved hepatitis B drug
Gilead has released a new hepatitis B drug, Vemlidy (ingredient: tenofovir ...
by Marian Chu
|
2017-05-25 10:29
라인
Hanmi ranked No. 1 in R&D investment
Hanmi Pharmaceuticals spent the largest amount of money on research and inv...
by Lee Hye-seon
|
2017-05-24 14:19
라인
Korean drugmakers challenge Pfizer’s smoking cessation therapy Champix
Korea’s drugmakers are challenging Champix (compound: Varenicline tartrate)...
by Lee Hye-seon
|
2017-05-24 13:16
라인
FDA approves 1st cancer drug for tumors with particular genetic feature
Merck & Co has won an accelerated approval from the U.S. Food and Drug Admi...
by Marian Chu
|
2017-05-24 12:37
라인
Rising demand for cosmeceuticals forces pharmaceuticals to jump into cosmetics market
Domestic pharmaceutical companies are competing to jump into the cosmetics ...
by Constance Williams
|
2017-05-24 11:35
라인
Approvals of incrementally modified drugs poured in last year
Korean pharmaceutical companies are now actively developing incrementally m...
by Lee Hye-seon
|
2017-05-23 10:55
라인
Ildong confident of its hepatitis drug surviving market competition
Ildong Pharmaceuticals is preparing to launch its chronic hepatitis B drug,...
by Marian Chu
|
2017-05-23 10:33
라인
Will Korea’s first stem cell therapy pass reexamination?
The pharmaceutical industry is following with interest whether Cellgram AMI...
by Nam Doo-hyun
|
2017-05-22 13:43
라인
No more calls for drug price hikes based on inaccurate statistics: MOHW
A pharmaceutical industry group has spread distorted information by repeate...
by Nam Doo-hyun
|
2017-05-19 15:13
라인
Celltrion launches anti-blood cancer biosimilar in Germany
Celltrion셀트리온 Inc. has launched its biosimilar to treat hematologic maligna...
by Constance Williams
|
2017-05-18 17:00
라인
Hanmi wins approval for 1st asthma-rhinitis combination drug
Hanmi Pharmaceutical said Wednesday that the company recently won the appro...
by Constance Williams
|
2017-05-17 17:32
라인
Young children of pharmaceutical firms’ owners have shares
Most pharmaceutical companies in Korea are run by owners’ families with the...
by Nam Doo-hyun
|
2017-05-17 17:18
라인
Ildong Pharmaceutical develops its first new drug
The Ministry of Food and Drug Safety (MFDS) has approved Besivo Tab. (compo...
by Lee Hye-seon
|
2017-05-17 14:42
라인
Sanofi, LG Chemical in court battle over Zemiglo
The legal battle between Sanofi-Aventis and LG Chemical over the copyright ...
by Lee Hye-seon
|
2017-05-16 16:41
라인
P2 trial over for GemVax’s prostate disease drug
GemVax & KAEL (CEO: Kim Sang-Jae김상재) completed its phase two clinical trial...
by Marian Chu
|
2017-05-15 11:00
라인
‘Korean pharmaceuticals should expand US export with new drugs’
With the United States stepping up protectionist measures, a state agency h...
by Nam Doo-hyun
|
2017-05-11 17:18
라인
Roche’s bladder cancer drug fails P3 trial
Roche’s Tecentriq (compound: atezolizumab), the first immunotherapeutic bla...
by Constance Williams
|
2017-05-11 16:25
라인
Celltrion adds reason why Remsima can target US market
Celltrion has secured additional grounds for its biosimilar Remsima, called...
by Constance Williams
|
2017-05-11 11:50
라인
Investors focus on Moon-related shares
The news of Moon Jae-in’s election victory is jolting the stock market, too...
by Nam Doo-hyun
|
2017-05-10 20:02
라인
FDA gives accelerated approval to bladder cancer drug
The U.S. Food and Drug Administration granted accelerated approval Tuesday ...
by Constance Williams
|
2017-05-10 11:11
-
이전
121
122
123
124
125
126
127
128
129
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top